Free CME activity on Cystic Fibrosis

Complimentary CME in Cystic Fibrosis     Free Online CME Activity Faculty J. Stuart Elborn, MD Jane Davies, MD Marcus A. Mall, MD Patrick A. Flume, MD Barry Plant, MD Current Strategies for the Long-term Assessment, Monitoring, and Management of Cystic Fibrosis Patients Treated with CFTR Modulator Therapy The content for this activity is based on the satellite symposium, “Current Strategies for the Long-term Assessment, Monitoring, and Management for Cystic Fibrosis Patients Treated with CFTR Modulator Therapy” that was presented at the 39th European Cystic Fibrosis Society Conference in Basel, Switzerland on June 10, 2016. The emergence of novel targeted agents, that directly correct CFTR loss function alleles, has created new treatment opportunities for patients with cystic fibrosis with advanced disease. Knowledge of the role of these agents in the clinical setting is quickly evolving and will require physicians stay acquainted with the latest data as well as evidence-based treatment guidelines in order to achieve optimized cystic fibrosis patient care. Educational Objectives Upon completion of this activity, participants will be better able to: 1.  Discuss the importance of accurate diagnosis, genomic evaluation, and early pharmacologic intervention. 2.  Analyze the current relevant and emerging clinical trial data. 3.  Develop strategies for the CFTR modulated treated patient for accurate life-long assessment, monitoring, and management. Upon successful completion of this activity you may receive up to 1.50 AMA PRA Category 1 Credits™ or 1.50 CBRN Contact Hours Begin CME Activity Financial Support This CME activity has been supported by an independent educational grant from Vertex Pharmaceuticals Incorporated. Provider Information Co-provided by the Elsevier Office of Continuing Medical Education, AcademicCME and Dannemiller. CME Credit (Physicians) The Elsevier Office of Continuing Medical Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The Elsevier Office of Continuing Medical Education designates this enduring activity for a maximum of 1.5 AMA PRA Category 1 Credits™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity The American Medical Association has an agreement of mutual recognition of Continuing Medical Education (CME) credits with the European Union of Medical Specialists (UEMS), the accreditation body for European countries. Physicians interested in converting AMA PRA Category 1 Credit™ to UEMS-European Accreditation Council for Continuing Medical Education CME credits (ECMECs) should contact the UEMS at mutualrecognition@uems.eu. CME Credit (Nurses) Dannemiller is a provider approved by the California Board of Registered Nursing (CBRN), Provider Number 4229. This activity has been approved for 1.5 contact hours. CBRN credit is not accepted by the Michigan and Utah State licensing boards. Full Course Listing Email Newsletter Signup This message has been sent to you on behalf of the Elsevier Office of CME team. If you do not wish to receive messages of this nature from us in the future, please click here. Please note that it may take several days to fully process your unsubscribe request. Copyright © 2016 Elsevier Inc. All rights reserved.| Privacy Policy Elsevier Inc., 65 East Butler Avenue, Suite 102, New Britain, PA 18901. | Elsevier Office of CME